Naturon, Inc.
Records under this name other than patents Naturon, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Naturon, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,034,576 | Xanthurenic acid derivative pharmaceutical compositions and methods related thereto Lapsed on the fee record Ended Oct 11, 2023 · USPTO record | Lapsed on the fee record | Ended Oct 11, 2023 | USPTO record |
| US 10,370,335 | Xanthurenic acid derivative pharmaceutical compositions and methods related thereto Lapsed on the fee record Ended Aug 6, 2023 · USPTO record | Lapsed on the fee record | Ended Aug 6, 2023 | USPTO record |
| US 7,183,314 | Compound for treatment of anxiety and methods of preparation and use thereof Term ended Term ended Aug 3, 2023 · USPTO record | Term ended | Term ended Aug 3, 2023 | USPTO record |
| US 10,323,357 | Functional substance adsorption device for fiber Lapsed on the fee record Ended Jun 18, 2023 · USPTO record | Lapsed on the fee record | Ended Jun 18, 2023 | USPTO record |
| US 6,740,677 | Methods of treating benzodiazepine site (BZD-S) associated syndromes using 2′ hydroxyflavonoids Term ended Term ended Aug 19, 2022 · USPTO record | Term ended | Term ended Aug 19, 2022 | USPTO record |
| US 8,697,674 | Xanthurenic acid derivative pharmaceutical compositions and methods related thereto Lapsed on the fee record Ended Apr 15, 2022 · USPTO record | Lapsed on the fee record | Ended Apr 15, 2022 | USPTO record |
| US 8,361,734 | Xanthurenic acid derivative pharmaceutical compositions and methods related thereto Lapsed on the fee record Ended Jan 29, 2021 · USPTO record | Lapsed on the fee record | Ended Jan 29, 2021 | USPTO record |